After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: N/A
Companies trading higher in after hours in reaction to news: CNAT +110.2% (Enters into exclusive option, collaboration and license agreement for the global development and commercialization of its first-in-class, orally active pan-caspase inhibitor emricasan with Novartis (NVS)), AUPH +5% (Enters into a long-term agreement with Lonza for the manufacturing of Voclosporin), OMED +2.7% (Initiated with a Buy at SunTrust), ECR +2.1% (Completes the sale of approximately 9,900 net acres in eastern Noble County and western Monroe County, Ohio for ~$63.8 mln), SRPT +1.4% (Announces that the EMA validated the previously submitted MAA for eteplirsen to treat Duchenne muscular dystrophy amenable to exon 51 skipping), FMI +1.2% (Confirms FDA approval for FoundationFocus CDxBRCA for use as a companion diagnostic to aid in identifying women with ovarian cancer for whom treatment with Rubraca is being considered).
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: NPTN -17.5%, WOR -6.7%,
Companies trading lower in after hours in reaction to news: REN -6% (To offer and sell 3.8 mln shares of its common stock in an underwritten public offering), IMMY -1.2% (To raise $9.8 mln in a private placements of units)
US After Hours : Conatus (CNAT) more than doubles on Novartis pact, NeoPhotonics (NPTN) slips on guidance revision